TrianglePUBLICATIONS · 11230488
High-dose interferon alfa-2b does not diminish antibody response to GM2 vaccination in patients with resected melanoma: results of the Multicenter Eastern Cooperative Oncology Group Phase II Trial E2696.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2001 Mar 1
- First author
- Kirkwood JM
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Kirkwood JM
- type
- Author
- name
- Ibrahim J
- type
- Author
- name
- Lawson DH
- type
- Author
- name
- Atkins MB
- type
- Author
- name
- Agarwala SS
- type
- Author
- name
- Collins K
- type
- Author
- name
- Mascari R
- type
- Author
- name
- Morrissey DM
- type
- Author
- name
- Chapman PB
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Kirkwood JM
- type
- Author
- name
- Ibrahim J
- type
- Author
- name
- Lawson DH
- type
- Author
- name
- Atkins MB
- type
- Author
- name
- Agarwala SS
- type
- Author
- name
- Collins K
- type
- Author
- name
- Mascari R
- type
- Author
- name
- Morrissey DM
- type
- Author
- name
- Chapman PB
- type
- Author
- bibliography ids
- nci-bib-9fd4f8b632a643edd1f8c760
- book metadata
- content sha256
- ef11c497152e9b734ec5b24ee0ae34db90d3cbc73991c13695171f8a82735d23
- document type
- citation
- dois
- 10.1200/JCO.2001.19.5.1430
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:11230488
- immutable id
- pubmed:11230488@ef11c497152e9b734ec5b24ee0ae34db90d3cbc73991c13695171f8a82735d23
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- Source null
- issn print
- 0732-183X
- issue
- 5
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 1430-6
- volume
- 19
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 11230488
- provenance
- batch id
- 30d2cd7affbbb92b6784
- provider
- NCBI PubMed ESummary
- record sha256
- ec3e5910ae532a758868af48ab3ef89546dc45bb2ffe7278f952d79e3b3a39ee
- response sha256
- ae7ed930f8b43c9e34eeae02f278f33f49c15777b81f742392c120eb64949120
- retrieved at
- 2026-09-09T23:45:39.779418+00:00
- publication date
- display
- 2001 Mar 1
- precision
- day
- year
- 2001
- publication types
- Clinical Trial
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
- Research Support, U.S. Gov't, P.H.S.
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- High-dose interferon alfa-2b does not diminish antibody response to GM2 vaccination in patients with resected melanoma: results of the Multicenter Eastern Cooperative Oncology Group Phase II Trial E2696.
Preserved source evidence · Not medical advice